baber/WOPTO huggingface dataset:
Patent NZ-565544-A (NZ)
Title: Associating a telephone call with a dialog based on a computer protocol such as SIP
Inventor: RAGHAV AMRITANSH
IPC: H04L12/66
Filed: 2006-07-20
Abstract: A method in a caller computing device for associating a telephone call with a caller so that a callee computing device can determine that a telephone call is from the caller is disclosed. An input is received from the caller to place a telephone call to the callee. The telephone call is to be established over a public telephone network. An indication that the caller is to initiate a telephone call with the callee via the public telephone network so that the callee can anticipate that an incoming call will be from the caller is sent, via an out-of-band communication mechanism that is out-of-band with respect to the public telephone network, to the callee computing device. In response to sending the indication, a response to the indication is received via the out-of-band communication mechanism from the callee computing device After receiving the response and after the telephone call has been initiated, upon receiving an indication that the initiated telephone call has been delivered to the callee as reported by the public telephone network, an indication that the delivered telephone call is from the caller so that the callee computing device is aware that the telephone call is from the caller is sent sending via the out-of-band communication mechanism to the callee computing device. Upon receiving an indication that the initiated telephone call has not been delivered to the callee as reported by the public telephone network, an indication that the telephone call has not been delivered to the caller so that the callee computing device is aware that any delivered telephone call is not from the caller is sent via the out-of-band communication mechanism to the callee computing device.
Patent NZ-574471-A (NZ)
Title: Methods for the preparation of salts of 2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol (quetiapine) and for the purification thereof
Inventor: HRADIL PAVEL
IPC: C07D281/16
Filed: 2006-08-31
Abstract: Disclosed is a method for the preparation of salts of 2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol (quetiapine) from the quetiapine base and the respective acid wherein the reaction is carried out in a mixture of solvents, the mixture being either a mixture of toluene and acetone or ethyl acetate, or that of toluene, water and acetone or ethyl acetate, wherein the amount of the aromatic hydrocarbon in the reaction mixture is up to 80 % by volume and the amount of water in the reaction mixture is up to 5% by volume.
Patent NZ-575334-A (NZ)
Title: Cosmetic composition for the treatment of skin and methods thereof
Inventor: ASCULAI SAMUEL S
IPC: A61Q19/00
Filed: 2007-09-07
Abstract: Disclosed is a cosmetic composition compatible with the skin comprising at least one compound selected from bioactive/biocompatible microparticulates selected from bioactive glass, bioactive ceramics, bioactive minerals and composites of these; and an intradermal delivery vehicle selected from hyaluronan, hyaluronic acid and/or salts and/or esters, fragments and subunits of hyaluronic acid to facilitate deposition and penetration of said bioactive microparticulates through tissue at a site to be treated.
Patent NZ-577315-A (NZ)
Title: Fungicidal mixtures of prothioconazole and thiram
Inventor: AMMERMANN EBERHARD
IPC: B60Q1/50
Filed: 2003-03-19
Abstract: Disclosed is a fungicidal mixture, comprising 2-[2-(1-chlorocyclopropyl)-3-(2-chlorophenyl)-2hydroxypropyl]-2,4-dihydro-[1,2,4]-triazole-3-thione (prothioconazole) of the formula (I) or a salt or adduct thereof, and thiram of formula (IX), wherein the weight ratio of prothioconazole to thiram is from 20:1 to 1:20.
Patent NZ-578825-A (NZ)
Title: New process for the synthesis of agomelatine
Inventor: HARDOUIN CHRISTOPHE
IPC: C07C231/02
Filed: 2009-08-03
Abstract: Disclosed is a process for the industrial synthesis of the compound of formula (I) which process is characterised in that the hydroxyl group of 7-methoxy-1-naphthol of formula (II) is converted into a leaving group and the compound is condensed in the presence of palladium with CH2=CH-R to yield a compound of formula (IV). The compound of formula (IV) is then subjected to catalytic hydrogenation to yield the compound of formula (V) which is subjected to a base or acid hydrolysis or to a binary reducing agent/acid system to yield the compound of formula (VI) or it hydrochloric salt. The compound or salt of formula (VI) is treated with sodium acetate and then acetic anhydride to yield the compound of formula (I) which is isolated as a solid. Also disclosed is the compound of formula (IV) and the use of the compound for synthesising agomelatine.
Patent NZ-579072-A (NZ)
Title: multi-fold panel assemblies with skewed support track, and frame structure to fully frame panels and for setting into a buidling opening
Inventor: BURGGRAAF DAVID FRANK
IPC: E05D15/26
Filed: 2002-08-14
Abstract: A closure assembly (40) of an opening in a building including at least two mutually pivoted panels (41, 42, 43) mounted with the mutual pivot axis (44) at least substantially vertical. The panels are movable between a closed condition whereby the at least two panels at least substantially in mutual alignment provide at least a partial closure of the opening in or substantially parallel to the plane of the opening, and an opened condition whereby the at least two panels, mutually disaligned by having pivoted mutually towards each other, are substantially clear of the plane of the opening. A proximate panel (41) is pivoted by a vertical pivot axis substantially in the plane of the opening at adjacent a vertical periphery of the opening (45). The distal region of distal panel (42) is supported by at least one supporting runner. The supporting runner is guided by a support track (51) which is skewed with respect to the plane of the opening and has the affect of spacing the supporting runner out of the plane of the opening at the vertical periphery. The closure assembly further includes a frame structure to set into that is contiguous the perimeter of the opening to thereby fully frame the panels.
Patent NZ-581483-A (NZ)
Title: Methods and apparatuses for obtaining beverages
Inventor: NAVARINI LUCIANO
IPC: A47J31/00
Filed: 2005-06-06
Abstract: Apparatus for preparing a coffee beverage inducing the passage of an extraction fluid through a dose (W) of coffee by heating the fluid, including separating means arranged downstream of the dose so as to separate a fraction of the beverage obtained with a prevalently liquid phase of the fluid from a further fraction of the beverage obtained with a prevalently steam phase of the fluid. A method for obtaining a coffee beverage is also disclosed. (62) Divided Out of 552444
Patent NZ-581647-A (NZ)
Title: Derivatives of fluorene, anthracene, xanthene, dibenzosuberone and acridine and uses thereof
Inventor: CHOLODY WIESLAW M
IPC: A61K31/185
Filed: 2008-05-09
Abstract: Disclosed herein are acridine compounds of formula Ia, wherein X is selected from NRA and C=ORA, and Y is O, S, NORA or NRA, and the other substituents are as defined within the specification, processes for their preparation, compositions comprising said compounds and uses thereof in preventing, treating or ameliorating cancer or tumor metastasis in a mammal.
Patent NZ-585003-A (NZ)
Title: a device for removing at least one teat cup from a teat of an animal
Inventor: LINGARD MIKE
IPC: A01J5/01
Filed: 2008-10-30
Abstract: The disclosure relates to a device for removing at least one teat cup (1a) from a teat of an animal. The device comprises a cylinder (2) provided with a movable piston (3) dividing an inner space of the cylinder in a first compartment (4) and a second compartment (5) and a valve mechanism (9) adapted to connect a vacuum source (8) to the first compartment (4) when it is in a first position and to break this connection when it is in a second position. The device comprises a passage (15) leading into the first chamber (4) and a valve member (16) adapted to allow a flow through the passage (15) to the first compartment (4) during occasions when an operator moves the teat cup (1a) from a storing position to a teat attaching position.
Patent NZ-592681-A (NZ)
Title: Container and lid arrangement with multiple snap-fit catches to secure the lid
Inventor: HIGGINSON MARK CHRISTOPHER
IPC: H02G3/08
Filed: 2009-10-29
Abstract: Disclosed is a container arrangement including a container and a separate lid. The lid and container are able to be detachably connected together by operating first and second different types of catches. The second type of catch is located on one of the lid or container and includes a ramp. The ramp is moulded integrally with one of the lid or container. The second type of catch operates by a snap-fit. The ramp assists in effecting the snap-fit by urging at least part of one portion of the lid or container relative to another portion of the other of the lid or container away from each other when the lid and container are urged towards each other. The second type of catch on the lid or container acting to effect connection by an edge of the catch moving past and extending under an edge of the other of the lid or container. There are multiple of the second type of catch spaced from each other along a side of the container or lid and adjacent to at least one port in the container and/or lid through which a cable may extend.
Patent NZ-592792-A (NZ)
Title: Heterocyclically substituted aryl compounds as hif inhibitors
Inventor: HARTER MICHAEL
IPC: A61K31/4245
Filed: 2009-10-31
Abstract: 592792 The present disclosure relates to novel heterocyclically substituted aryl compounds of Formula I, to processes for preparation thereof, to the use thereof for treatment and/or prevention of disorders and to the use thereof for production of medicaments for treatment and/or prevention of disorders, especially for treatment and/or prevention of hyperproliferative and angiogenic disorders, and those disorders which arise as a result of a metabolic adaptation to hypoxic states. Such treatments can be effected as monotherapy or else in combination with other medicaments or further therapeutic measures. Compounds of the disclosure include: (4-Methylpiperazin-1-yl){ 5-[(5-methyl-3-{ 3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazol-5-yl} -1H-pyrazol-1-yl)methyl]pyridin-2-yl} methanone, 1-Methyl-4-{ 4-[(5-methyl-3-{ 3-[4-(trifluoromethoxy)phenyl)-1,2,4-oxadiazol-5-yl} -1H-pyrazol-1-yl)methyI]pyridin-2-yl} piperazine, 1-Cyclopropyl-4- { 5-[(5-methyl-3-{ 3-[4-(1,1,1-trifluoro-2-methylpropan-2-yl)phenyl]-1,2,4-oxadiazol-5-yl} -1H-pyrazol-1-yl)methyl]pyridin-2-yl} piperazine, 1-[4-({ 3-[3-(4-tert-Butylphenyl)-1,2,4-oxadiazol-5-yI]-5-methyl-1H-pyrazol-1-yl} methyl)pyridin-2-yI]-4-cyclopropylpiperazine, 1-{ 4-[(5-Methyl-3-(3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazol-5-yl} -1H-pyrazol-1-yl)methyl]pyridin-2-yl} 4-(2,2,2-trifluoroethyl)-1,4-diazepan, { 3-[(3-{ 3-[4-(1-MethoxycycIobutyI)phenyl]-1,2,4-oxadiazol-5-yl} -5-methyl-1H-pyrazol-1-yI)methyl]phenyl} (4-methylpiperazin-1-yl)methanone and (4-Methylpiperazin-1-yl)(3-{ [5-methyl-3-(3-{ 4-[1-(trifluoromethyl)cyclopropyl]phenyl} -1,2,4-oxadiazol-5-yl)-1H-pyrazol-1-yI]methyl} phenyl)methanone,
Patent NZ-596025-A (NZ)
Title: [4-(6-halo-7-substituted-2,4-dioxo-1,4-dihydro-2h-quinazolin-3-yl)-phenyl]-5-chloro-thiophen-2-yl-sulfonylureas and forms and methods related thereto
Inventor: ZHANG XIAOMING
IPC: A61K31/44
Filed: 2006-11-03
Abstract: Disclosed herein is a process for preparing a compound of formula (I), wherein the substituents are as defined within the specification, comprising the steps of acylating the amino group of a compound of formula II with a compound of formula III under basic acylation conditions in the presence of an appropriate solvent to produce a compound of formula IV; reacting the compound of formula IV, with an amine containing compound V, in the presence of a basic catalyst and a solvent at a suitable temperature to produce a cyclized quinazoline derivative of formula VI replacing the leaving group L1 of the compound of formula VI with R1 by reacting the compound of formula R1H to provide a compound of formula VII reacting the compound of formula VII with a compound of the formula VIII to provide a compound of formula I and optionally, producing a salt, solvate, or hydrate of the compound of formula I. Also disclosed are the compounds of formula IV, processes for the preparation of compounds VI, VII.
Patent NZ-597246-A (NZ)
Title: Modular platform, walkway or ramp which is height adjustable, having numerous optional features
Inventor: TREVOR ROSS SUGGATE
IPC: E04F11/00
Filed: 2009-01-08
Abstract: 597246 Disclosed is a deck support which is adjustable to support a deck of a scaffolding, modular or temporary platform, walkway or ramp at a predetermined elevation. The deck support comprises a prefabricated moveable member and a corresponding elongate member, an engagement between the prefabricated moveable member and the elongate member retaining the prefabricated moveable member to the elongate member while allowing longitudinal movement of the prefabricated moveable member relative to the elongate member. The prefabricated moveable member has an extension arranged to directly support the deck laterally of the elongate member by contact with an underneath surface of the deck. The prefabricated moveable member is locatable at predetermined longitudinal positions relative to the elongate member, and comprises a slideable member arranged to slide axially relative to the elongate member. The slidable member is a collar, sleeve or other tubular member or partly tubular member having a section corresponding to a partial section of a tubular member.
Patent NZ-600010-A (NZ)
Title: Novel crystalline forms of bosentan, processes for their preparation and uses thereof
Inventor: GAITONDE ABHAY
IPC: A61K31/506
Filed: 2008-10-24
Abstract: 600010 Disclosed is Crystalline form 6 of bosentan (4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-(2-pyrimidinyl)-pyrimidin-4-yI]-benzenesulfonamide), characterized by an X-ray diffraction pattern comprising peaks at values 3.87, 7.51, 8.84, 11.14, 18.74 and 23.30 -0.2 plus or minus 0.2 degrees theta. The crystalline form of bosentan is useful for treating or preventing an endothelien receptor mediated disorder such as cardiovascular disorders. Specific cardiovascular disorders treated include hypertension, pulmonary hypertension, ischemia, vasospasm or angina pectoris.
Patent NZ-601325-A (NZ)
Title: Compositions and methods for treating glioblastoma gbm
Inventor: BANGIO LIVNAT
IPC: A61K39/00
Filed: 2011-01-05
Abstract: Discloses the use of a viral vector in the preparation of a medicament for the treatment of a malignant glioma, said viral vector comprising; (i) a first polynucleotide sequence encoding a Fas-chimera (Fas-c); and (ii) a second polynucleotide sequence encoding an endothelial cell-specific promoter or a perendothelial cell-specific promoter.
Patent NZ-615973-A (NZ)
Title: Use of bacterial endotoxins and lipoteichoic acids to improve postpartal health and productivity of dairy cows and their newborns
Inventor: AMETAJ BURIM N
IPC: A61K38/16
Filed: 2012-02-29
Abstract: Disclosed is a method for treating or preventing a metabolic disorder in a nonhuman subject, the method comprising administering to the non-human subject a bacterial endotoxin and a lipoteichoic acid, separately, simultaneously or sequentially, with the proviso that when the endotoxin is LPS, the metabolic disorder is not Laminitis.
Patent NZ-623572-A (NZ)
Title: Mobile multimedia real-time transcoding system, device, storage medium and method
Inventor: HUANG YAN
IPC: G06F17/30
Filed: 2012-07-13
Abstract: Disclosed is a mobile multimedia real-time transcoding playing system based on offline downloading. The system comprises a client, a task scheduling and managing server, an offline downloading and transcoding server cluster and a storage server. The client is adapted to submit an offline downloading and transcoding task request to the task scheduling and managing server. The offline downloading and transcoding task request comprises a target mobile device type selected by a user and a target format designated by the user and obtain a requested multimedia resource. The task scheduling and managing server is adapted to transmit an offline downloading and transcoding task request of a client, and schedule the distributed offline downloading and transcoding server cluster. The offline downloading and transcoding server cluster is distributed and is adapted to accept scheduling of the task scheduling and managing server, perform an offline downloading and transcoding task in a manner of performing offline downloading and transcoding in parallel according to a target mobile device type selected by the user or a target format designated by the user. The storage server is adapted to store a multimedia resource which is downloaded and transcoded by the offline downloading and transcoding server cluster. The offline downloading and transcoding server cluster is further adapted to report basic configuration information and load information of the offline downloading and transcoding server cluster to the task scheduling and managing server. The task scheduling and managing server is further adapted to allocate the offline scheduling and transcoding task to the offline downloading and transcoding server cluster according to the basic configuration information and the load information submitted by the offline downloading and transcoding server cluster. The multimedia resource comprises data slices. The offline downloading and transcoding server cluster is further adapted to receive an offset of a designated slice submitted by the client when the client needs to designate another slice which belongs to a same file with a current slice being played or previewed, perform the offline downloading and transcoding task from the designated slice according to the offset of the slice.
Patent NZ-624873-A (NZ)
Title: Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for prevention or reduction of organ dysfunction or organ failure in a patient having a chronic or acute disease or acute condition
Inventor: BERGMANN ANDREAS
IPC: C07K16/26
Filed: 2012-11-16
Abstract: Discloses the use of an anti-Adrenomedullin (ADM) antibody or an anti-ADM antibody fragment binding to adrenomedullin or anti-ADM non-Ig scaffold binding to adrenomedullin in the manufacture of a medicament for use in therapy of an acute disease or acute condition of a patient for prevention or reduction of organ dysfunction or prevention of organ failure in said patient, wherein said antibody or antibody fragment or non-Ig scaffold binds to a region of at least 4 amino acids within the sequence of aa1-42 of mature human ADM (SEQ ID NO: 24), and wherein said organ is selected from the group comprising heart, kidney, liver, lungs, pancreas, small intestines and spleen, wherein the sequences are as defined in the complete specification.
Patent NZ-701575-A (NZ)
Title: Combination therapy involving antibodies against claudin 18.2 for treatment of cancer
Inventor: SAHIN UGUR
IPC: C07K16/30
Filed: 2013-05-21
Abstract: The present invention provides a combination therapy comprising an antibody having the ability of binding to CLDN18.2 in combination with an agent stimulating cells for effectively treating and/or preventing diseases associated with cells expressing CLDN18.2, including cancer diseases such as gastric cancer, esophageal cancer, pancreatic cancer, lung cancer, ovarian cancer, colon cancer, hepatic cancer, head-neck cancer, and cancer of the gallbladder and metastases thereof.
Patent NZ-707252-A (NZ)
Title: Enhanced strength grade level utilities enclosure
Inventor: BURKE EDWARD J
IPC: H02G9/10
Filed: 2013-10-28
Abstract: An enhanced strength grade level utility enclosure comprises a vertical wall structure having an upright inner wall panel (46) extending from an upper edge to a bottom edge of the structure. The inner wall panel (46) has an inside face spanning the enclosure’s interior. One or more narrow, vertically extending slotted regions (58) are recessed in the inside face of the wall panel. Upright rigid support bars (60), optionally adapted for use as cable racks, are positioned in and rigidly affixed to separate slotted regions on the wall panel. The support bars (60) provide a continuous means of rigid vertical support from the upper edge down to the bottom edge of the enclosure’s wall structure. The recessed support bars, in combination with the vertical wall structure, provide enhanced wall strength in excess of industrial vertical side wall and center load test standards.
Patent NZ-707799-A (NZ)
Title: Metal Connector, I-Beams and a process for their manufacture
Inventor: WILLIAM ROY CHIVERS
IPC: E04C3/292
Filed: 2015-05-05
Abstract: The present invention relates to a metal web connector and a composite I-beam suitable for use in the construction of buildings. The present invention also relates to a process for making a metal connector and a process for making an I-beam. The I-beam can be used for any suitable purpose, including without limitation, use as a bearer, joist, lintel and alike, and can be used to support flooring and roofing in both domestic and commercial buildings. The inventive concept being the projecting formations extending outwardly from a raised inner ring circumventing each aperture, the projecting formations terminating in a non-pointed outer extremity which help secure the timber member attached to the I beams. The non-pointed projecting formations of the present device allow for movement of the web connector over the surface of the timber flange members without piercing or grabbing, and thereby allow the web connector to be correctly positioned and straightened prior to engagement
Patent NZ-710093-A (NZ)
Title: Ostomy appliance
Inventor: WILTSHIRE NEIL
IPC: A61F5/445
Filed: 2014-01-28
Abstract: The invention solves the problem of how to make an ostomy appliance with a viewing portion that is easier, and thus more cost effective, to manufacture, the ostomy appliance having first and second walls connected to each other at or near their peripheries, the first wall having a stoma-receiving opening, and a waste collecting cavity defined between the first and second walls, wherein the second wall includes viewing portion through which the stoma-receiving opening can be viewed.
Patent NZ-718164-A (NZ)
Title: Disease resistance loci in onion
Inventor: RICK JONES
IPC: A01H5/00
Filed: 2014-09-09
Abstract: Disclosed is a method of detecting in at least one onion plant a genotype associated with disease resistance, the method comprising the step of: (i) detecting in at least one onion plant an allele of at least one polymorphic nucleic acid that is associated with disease resistance, wherein the polymorphic nucleic acid is in or genetically linked to an onion genomic region defined by loci NQ0345038 (SEQ ID NO:3) and NQ0257326 (SEQ ID NO:23) on linkage group 2 (LG2), conferring resistance to Fusarium basal rot (FBR). Further disclosed are methods of producing a plant or introgression methods with the FBR resistance as defined.
Patent NZ-725380-A (NZ)
Title: Asynchronous multicarrier communications
Inventor: BHUSHAN NAGA
IPC: H04L27/26
Filed: 2015-05-12
Abstract: Apparatuses and methods for performing asynchronous multicarrier communications are provided. One such method involves generating, at a first wireless device, a waveform including one or more carriers, shaping the waveform to reduce interference between the waveform and adjacent waveforms, and transmitting, on a spectrum, the shaped waveform asynchronously.